Chad Messer Analyst PerformanceSenior Life Science Equity Analyst at Lake Street CapitalChad Messer is a stock analyst at Lake Street Capital in the medical sector, covering 28 publicly traded companies. Over the past year, Chad Messer has issued 11 stock ratings, including and buy recommendations. While full access to Chad Messer's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Chad Messer's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings133 Last 11 YearsBuy Recommendations97.71% 128 Buy RatingsCompanies Covered28 Unique Companies Ratings Distribution131RatingsDistribution of strong buy, buy, hold, and sell ratings by Chad Messer.RatingPercentageCount Strong Buy3.1%4 ratings Buy94.7%124 ratings Hold2.3%3 ratings Sell0.0%0 ratingsOut of 131 total stock ratings issued by Chad Messer at Lake Street Capital, the majority (94.7%) have been Buy recommendations, followed by 3.1% Strong Buy and 2.3% Hold.Best & Worst CallsBest Call0000.0%VCELMar 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TLOGMar 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ89.3% of companies on NASDAQ25 companiesOTCMKTS7.1% of companies on OTCMKTS2 companiesNYSEAMERICAN3.6% of companies on NYSEAMERICAN1 companyChad Messer, an analyst at Lake Street Capital, currently covers 28 companies listed on NASDAQ, OTCMKTS and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical28 companies100.0%Chad Messer of Lake Street Capital specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE19 companies67.9%MED - DRUGS4 companies14.3%PHARMACEUTICAL PREPARATIONS2 companies7.1%BIOTECHNOLOGY1 company3.6%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company3.6%SURGICAL APPLIANCES & SUPPLIES1 company3.6% Chad Messer's Ratings History at Lake Street Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCGENCompugen4/7/2026Initiated Coverage$2.18$6.00Buy$0.0000.00% ROIIMNMImmunome12/16/2025Boost Price Target$23.82$32.00Buy$0.0000.00% ROIOSTXOS Therapies11/18/2025Lower Price Target$1.68$17.00Buy$0.0000.00% ROIGNLXGenelux10/21/2025Set Price Target$6.41$16.00$0.0000.00% ROIGNLXGenelux10/21/2025Initiated Coverage$6.51$16.00Buy$0.0000.00% ROIMNPRMonopar Therapeutics9/23/2025Initiated Coverage$63.66$106.00Buy$0.0000.00% ROIMNPRMonopar Therapeutics9/23/2025Initiated Coverage$73.04$106.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics8/15/2025Boost Price Target$5.40$75.00Buy$0.0000.00% ROIONCYOncolytics Biotech8/13/2025Initiated Coverage$0.86$7.00Buy$0.0000.00% ROICOYACoya Therapeutics7/9/2025Initiated Coverage$6.11$16.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics5/20/2025Initiated Coverage$6.52$80.00Buy$0.0000.00% ROIIMNMImmunome4/2/2025Initiated Coverage$6.26$23.00Buy$00.0000.00% ROIOSTXOS Therapies4/2/2025Initiated Coverage$1.33$19.00Buy$0.0000.00% ROILTRNLantern Pharma4/2/2025Initiated Coverage$3.31$25.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenMorgan StanleyRoyal Bank Of CanadaBerenberg BankUBS GroupCitigroupBarclaysWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
